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NEONATAL ABSTINENCE SYNDROME
Marissa Thompson, BSN Student, Barbara McClaskey, Ph.D. – Faculty
Irene Ransom Bradley School of Nursing, Pittsburg State University
INTRODUCTION
❖ Population: Infants with NAS
❖ Intervention: Standardizing care for 
NAS in hospitals
❖ Comparison: No standardized care
❖ Outcome: Decrease in length of 
pharmacological use & hospital stay
❖ Time frame: From the time the infant 
is born until they are discharged
PICOT
❖ The purpose of this study is to see if 
standardizing care for infants born with 
Neonatal Abstinence Syndrome (NAS) 
helps decrease the length of 
pharmacological treatment and the 
overall hospital stay.
PURPOSE
❖ Neonatal abstinence syndrome
❖ When a pregnant woman uses narcotics, they cross 
the placenta to the fetus. The fetus then becomes 
dependent on the drug. When an infant is born, they 
are still dependent on the drug, however they are no 
longer receiving it. Withdrawal occurs due to the 
infant’s central nervous system becoming 
overstimulated. Infants may experience tremors, 
irritability, hyperactive reflexes, seizures, poor feeding 
and suck, sweating or fever. 55% to 94% of infants 
exposed to opioids in utero will have withdrawal 
symptoms
❖ Nationwide Children’s Hospital Study
❖ This hospital partnered with 5 other hospitals in Ohio 
for this study.
❖ This study was done to develop a standardized 
practice that focused on communication between 
healthcare workers, improving reliability of the 
Finnegan NAS scoring system & developing an 
initiation and weaning protocol
❖ They found that compliance with standardized 
protocol may be more significant than which specific 
pharmacologic intervention is used
❖ When using methadone with a standardized 
protocol, the length of stay was decreased
❖ NAS Taskforce developed
❖ Meet monthly
❖ Discuss problems related to the management of 
NAS, ways to improve the processes & shared 
improvements with other neonatal units
❖ Yale New Haven’s Children Hospital Study
❖ Average length of stay for infants with NAS was 22.4 
days without standardized treatment
❖ After implementing standardized care, the average 
length of stay was 5.9 days
❖ Rapid morphine weaning & as-needed morphine 
protocol established
❖ Infants treated with morphine decreased from 
98% to 14%
❖ Vermont Oxford Network Quality Improvement 
Collaborative
❖ 199 birthing centers and NICU’s participated
❖ Goal was to determine if these hospitals participating 
had decreased length of stay and treatment for 
infants with NAS
❖ Policies developed for standardized NAS scoring 
increased from 44.8% to 76.5% 
❖ Non-pharmacologic policies improved from 59.1% to 
84.0%
❖ Standardized pharmacologic treatment increased 
from 68% to 91.6%
MATERIALS / METHODS
❖ Using standardized guidelines for infants with 
NAS
❖ Using nonpharmacologic and pharmacologic 
treatment
❖ Using standardized medication weaning 
guidelines
❖ Identifying infants who are at risk for NAS
❖ Educating women who are pregnant about the 
risks of narcotic use during pregnancy
❖ Using the Finnegan NAS scoring system
❖ Having a taskforce to evaluate outcomes and 
problems to provide the best care
Neonatal Abstinence Syndrome (NAS) is a 
rising concern in infants. This is due to more 
women taking narcotics while they are 
pregnant. Approximately 21,732 infants were 
diagnosed with Neonatal Abstinence Syndrome 
in 2012. Since then, the number has increased 
by five times. There is no definitive 
standardized care for NAS. Studies have been 
done to look at whether or not standardizing 
care influences the length of stay and the 
length of pharmacologic therapy in infants with 
NAS.
❖ Following standardized treatment guidelines 
for infants with NAS
❖ Decreased length of stay in the hospital
❖ Decreased length of pharmacologic 
treatment
❖ Using nonpharmacologic measures prior to 
pharmacologic
❖ Reliably using the scores of the Finnegan 
NAS scoring system to determine correct 
treatment options
INTERVENTIONS
RESULTS / CONCLUSION
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